Clinical Edge Journal Scan

Clinical Edge Journal Scan

ER+ HER2− early BC: Patients with PEPI 0-1/pCR can safely skip adjuvant chemotherapy

Publish date: August 22, 2022

• Read More

Clinical Edge Journal Scan

Oral paclitaxel+encequidar offers a possible alternative to IV paclitaxel in metastatic BC

Publish date: August 22, 2022

• Read More

Clinical Edge Journal Scan

ERBB2-positive BC: Adding atezolizumab to PATH shows acceptable pCR rate in phase 2

Publish date: August 22, 2022

• Read More

Clinical Edge Journal Scan

TNBC: First-line nab-paclitaxel+cisplatin effective and safe in phase 3

Publish date: August 22, 2022

• Read More

Clinical Edge Journal Scan

Bed boost after WBI reduces local recurrence of ductal carcinoma in situ in the breast

Publish date: August 22, 2022

• Read More

Clinical Edge Journal Scan

Pembrolizumab+chemotherapy improves OS in a subgroup of patients with advanced TNBC

Publish date: August 22, 2022

• Read More

Clinical Edge Journal Scan

ctDNA predicts outcomes in CRC after surgery and ACT

Publish date: August 21, 2022

• Read More

Clinical Edge Journal Scan

Metformin use not linked with CRC incidence in T2D patients on evading time-related biases

Publish date: August 21, 2022

• Read More

Clinical Edge Journal Scan

Metastatic CRC: Foods rich in vegetable fats prolong survival

Publish date: August 21, 2022

• Read More

Clinical Edge Journal Scan

How efficient is neoadjuvant chemotherapy in mismatch repair deficient colon cancer?

Publish date: August 21, 2022

• Read More

Clinical Edge Journal Scan

Specific clinical features indicate more timely prediagnostic investigations or referral for CRC

Publish date: August 21, 2022

• Read More

Pages

• « first
• …
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• …
• last »